These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2142401)
1. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)]. Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401 [No Abstract] [Full Text] [Related]
2. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach]. Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs. Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969 [TBL] [Abstract][Full Text] [Related]
4. [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR]. Noda K; Watanabe Y; Ikeda M; Takeuchi K; Hasegawa K; Kinugasa M; Sekiba K; Kobashi Y; Ohiwa T; Odagiri H Gan To Kagaku Ryoho; 1991 Dec; 18(15):2551-5. PubMed ID: 1836128 [TBL] [Abstract][Full Text] [Related]
5. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area]. Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer. Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769 [TBL] [Abstract][Full Text] [Related]
7. [5-Fluorouracil level and pyrimidine nucleoside phosphorylase activity in cancer patients after oral administration of doxifluridine (5'-DFUR)]. Maeda H; Miyamoto T; Mochinaga N; Tsunoda T Gan To Kagaku Ryoho; 1991 May; 18(6):965-9. PubMed ID: 1827573 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer]. Yamasaki Y; Kuwata K; Hioki K; Sowa M; Hirakawa K; Okajima K; Isozaki H; Iwanaga T; Furukawa H; Nakano H; Watanabe A; Takami M; Tsukahara Y; Matsunaga S; Kikkawa N; Gotoh T; Tokuda H; Takahashi S; Toyohara M; Yagi M; Takebayashi J; Nakajima T; Miyazaki H; Kuwata H; Nakazato H Gan To Kagaku Ryoho; 1998 Aug; 25(10):1549-56. PubMed ID: 9725048 [TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer]. Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321 [TBL] [Abstract][Full Text] [Related]
10. [Significance of 5'-deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers--activity of pyrimidine nucleoside phosphorylase (PyNPase) and serum immunosuppressive acidic protein (IAP)]. Murakami N; Hirano M; Saito H; Nagao S; Arano Y; Kikuchi T; Ishikawa N; Kurokawa M; Kitsukawa H Gan To Kagaku Ryoho; 1996 Dec; 23(14):1959-66. PubMed ID: 8978804 [TBL] [Abstract][Full Text] [Related]
11. [Study on the relationship between concentrations of 5-FU and PyNPase activity in tumor tissue during oral 5'-DFUR treatment in patients with advanced colorectal cancer]. Watanabe K; Igarashi T; Suzuki M; Hayashi T; Yoshida K; Hanyu F Gan To Kagaku Ryoho; 1994 Feb; 21(2):243-8. PubMed ID: 8311496 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration. Hamada A; Fukushima S; Morinaga A; Saneyoshi M; Kawaguchi T; Nakano M Biol Pharm Bull; 1993 Dec; 16(12):1297-300. PubMed ID: 8130783 [TBL] [Abstract][Full Text] [Related]
13. [The alteration of PyNPase activity in breast cancers due to preoperative oral administration of 5'-DFUR]. Akao S; Yoshida M; Abe S; Kojima M; Ishikawa H; Soma R Gan To Kagaku Ryoho; 1997 Apr; 24(6):685-90. PubMed ID: 9126305 [TBL] [Abstract][Full Text] [Related]
14. [5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues]. Hara Y Gan To Kagaku Ryoho; 1984 Oct; 11(10):2133-43. PubMed ID: 6237613 [TBL] [Abstract][Full Text] [Related]
15. The relationship between clinicopathological factors and the reduction of pyrimidine nucleoside phosphorylase activity after preoperative administration of 5'-deoxy-5-fluorouridine. Honda T; Inagawa H; Nishizawa T; Yoshimura H; Yamamoto I; Soma G Anticancer Res; 2010 Aug; 30(8):3207-11. PubMed ID: 20871042 [TBL] [Abstract][Full Text] [Related]
16. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients]. Akao S; Inoue K Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422 [TBL] [Abstract][Full Text] [Related]
17. [A study on pre-operative administration of 5'-DFUR in carcinomas of the gastric, breast, thyroid and colon]. Munemoto Y; Omura K; Hikishima H; Okada Y; Hayashi H; Adachi I; Douden K; Watanabe Y; Iwa T Gan To Kagaku Ryoho; 1990 Dec; 17(12):2415-20. PubMed ID: 2148066 [TBL] [Abstract][Full Text] [Related]
18. [Pyrimidine nucleoside phosphorylase activity, 5-fluorouracil concentration and thymidylate synthase inhibition rate in colorectal cancer after oral administration of 5'-doxifluridine]. Tomoda H; Morita M; Matsuoka H; Baba H; Taketomi A; Kohnoe S; Seo Y; Saito T Gan To Kagaku Ryoho; 1997 Jun; 24(8):971-4. PubMed ID: 9212806 [TBL] [Abstract][Full Text] [Related]
19. [A study of preoperative administration of 5'-DFUR in patients with colo-rectal cancer]. Haruta A; Umeno T; Tanaka S; Toriya H; Jyozaki H; Ikeda S Gan To Kagaku Ryoho; 1994 Oct; 21(14):2427-30. PubMed ID: 7944487 [TBL] [Abstract][Full Text] [Related]
20. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR]. Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]